Loading...
XSES
BSL
Market cap1.26bUSD
Apr 07, Last price  
0.92SGD
1D
-5.64%
1Q
9.52%
Jan 2017
-35.66%
Name

Raffles Medical Group Ltd

Chart & Performance

D1W1MN
P/E
27.46
P/S
2.27
EPS
0.03
Div Yield, %
2.61%
Shrs. gr., 5y
0.49%
Rev. gr., 5y
7.56%
Revenues
752m
+6.15%
112,898,000134,248,000168,659,000200,769,000218,610,000239,123,000272,783,000311,633,000340,989,000374,641,000410,535,000473,608,000477,583,000489,135,000522,038,000568,203,000723,791,000766,537,000708,032,000751,564,000
Net income
62m
-30.96%
11,958,00015,713,00035,863,00031,547,00037,882,00045,265,00050,396,00056,849,00084,892,00067,639,00069,291,00070,210,00070,779,00071,056,00060,273,00065,891,00084,171,000143,214,00090,150,00062,243,000
CFO
86m
-54.44%
15,626,00019,663,00040,071,00040,074,00047,209,00049,210,00063,258,00069,545,00071,191,00093,496,00072,816,00078,854,00082,693,00091,528,000111,147,000133,146,000160,112,000196,225,000189,312,00086,254,000
Dividend
May 13, 20250.025 SGD/sh
Earnings
Apr 25, 2025

Profile

Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through Healthcare Services, Hospital Services, and Investment Holdings segments. Its flagship hospital is the Raffles Hospital, a tertiary care hospital that offers cancer, children and women care, Chinese medicine, counselling, dental, dialysis, diabetes and endocrinology, ear, nose, throat, eye, fertility, heart, internal medicine, neuroscience, pain management, rehabilitation, orthopedic, skin and aesthetics, surgery, nuclear medicine, and urology services. The company also offers emergency services, family medicine services, health screening, and various multi-disciplinary specialist clinic services. In addition, it trades in pharmaceutical and nutraceutical products, and diagnostic equipment; provides advisory and consultancy services, and develops IT solutions; and engages in research and experimental development on biotechnology, and life and medical science. Raffles Medical Group Ltd was founded in 1976 and is based in Singapore.
URL
https://www.rafflesmedicalgroup.com/
IPO date
Apr 11, 1997
Employees
2,800
Domiciled in
SG
Incorporated in
SG

Valuation

Title
SGD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
751,564
6.15%
708,032
-7.63%
766,537
5.91%
Cost of revenue
265,426
392,097
126,556
Unusual Expense (Income)
NOPBT
486,138
315,935
639,981
NOPBT Margin
64.68%
44.62%
83.49%
Operating Taxes
24,680
28,349
48,002
Tax Rate
5.08%
8.97%
7.50%
NOPAT
461,458
287,586
591,979
Net income
62,243
-30.96%
90,150
-37.05%
143,214
70.15%
Dividends
(44,576)
(70,683)
(52,015)
Dividend yield
2.82%
3.50%
1.99%
Proceeds from repurchase of equity
280
(5,698)
(18,311)
BB yield
-0.02%
0.28%
0.70%
Debt
Debt current
16,397
27,785
19,326
Long-term debt
103,957
134,673
99,917
Deferred revenue
Other long-term liabilities
4,205
8,083
56,478
Net debt
(223,317)
(181,140)
(409,558)
Cash flow
Cash from operating activities
86,254
189,312
196,225
CAPEX
(19,270)
(20,525)
(25,299)
Cash from investing activities
(9,873)
(21,419)
(22,832)
Cash from financing activities
(76,203)
(81,549)
(183,702)
FCF
481,513
258,355
650,269
Balance
Cash
343,671
343,598
253,127
Long term investments
275,674
Excess cash
306,093
308,196
490,474
Stockholders' equity
1,065,272
1,075,335
1,057,298
Invested Capital
851,259
868,435
642,920
ROIC
53.67%
38.06%
88.74%
ROCE
41.72%
26.85%
56.06%
EV
Common stock shares outstanding
1,860,824
1,868,552
1,866,347
Price
0.85
-21.30%
1.08
-22.86%
1.40
2.19%
Market cap
1,581,701
-21.62%
2,018,036
-22.77%
2,612,886
1.64%
EV
1,373,597
1,853,010
2,218,678
EBITDA
529,226
354,182
680,197
EV/EBITDA
2.60
5.23
3.26
Interest
5,779
6,078
6,882
Interest/NOPBT
1.19%
1.92%
1.08%